Event Abstract

Crosslinked mucin hydrogels for drug delivery

  • 1 Massachusetts Institute of Technology, Bioengineering, United States
  • 2 Université Claude Bernard - Lyon 1, Ingénierie des Matériaux Polymères, France

Introduction: The sustained delivery of both hydrophobic and hydrophilic drugs from hydrogels remains a challenge that requires the design of complex multifunctional synthetic polymers. In this work we exploit mucin glycoproteins, the gel-forming building blocks of natural mucus to deliver both hydrophobic and hydrophilic drugs. Mucins are a family of high molecular weight proteins which are densely glycosylated. Their central protein backbone contains hydrophobic and charged domains, while the mucin-associated glycans provide hydrogen bonding capabilities, high hydration, and negative charges. The biochemical versatility of mucins represent potential binding sites for certain drugs. If assembled into hydrogels, mucins could prevent drugs from freely diffusing out, leading to their sustained delivery.

Materials and Methods: We generated methacrylated mucins which assembled into a covalently crosslinked mucin hydrogel when exposed to UV light. The gel's structure was observed by scanning electron microscopy, its rheological properties measured using a parallel plate rheometer, and its degradation profile when exposed to proteases was assessed by measuring weight changes. Fluorescently labeled paclitaxel, a hydrophobic anticancer drug and polymyxin B, a positively charged hydrophilic antibiotic were chosen as model drugs. The drugs were mixed with the mucin before gel formation, and their release from the gel followed over seven days. The activity of the released drugs was tested by measuring the decrease in viability of HeLa epithelial cell when exposed to paclitaxel and the killing of E. coli bacteria by polymyxin B.

Results and Discussion: The rheological properties of the mucin gels were dominated by an elastic component, and the storage and loss moduli were maintained over four weeks when stored in buffer at 37ºC. The gel was resistant to the alpha-chymotrypsin protease, but showed some degradation in pronase. Our data show that paclitaxel, a model hydrophobic anticancer drug and polymyxin B, a positively charged hydrophilic model antibiotic drug, are retained in the gel and release linearly over more than seven days. This was in contrast with the burst release of the negatively charged poly-glutamic acid and neutral dextran molecules.

We show that after three weeks of release, sufficient amounts of active paclitaxel were present to reduce HeLa cell viability. In addition, we show that the mucin gels can sequester polymyxin B and release it in sufficient amounts to inhibit bacteria growth over a month.

Conclusions: This work suggests that mucins may have potential as a new building block for functional biomaterials that could exploit the divers set of functionalities mucins polymers naturally exhibit[1]. Amongst others, these include: interactions with drug, proteins, lipids, viruses, bacteria and immune cells, strong hydration, lubrication, and cell repellent properties.

References:
[1] Duffy, C. V., David, L. & Crouzier, T. Covalently-crosslinked mucin biopolymer hydrogels for sustained drug delivery. Acta Biomater. 20, 51–59 (2015).

Keywords: Hydrogel, Drug delivery, material design, biomacromolecule

Conference: 10th World Biomaterials Congress, Montréal, Canada, 17 May - 22 May, 2016.

Presentation Type: General Session Oral

Topic: Naturally-derived materials and biopolymers

Citation: Duffy CV, David L and Crouzier T (2016). Crosslinked mucin hydrogels for drug delivery. Front. Bioeng. Biotechnol. Conference Abstract: 10th World Biomaterials Congress. doi: 10.3389/conf.FBIOE.2016.01.01982

Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.

The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.

Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.

For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.

Received: 27 Mar 2016; Published Online: 30 Mar 2016.

* Correspondence:
Dr. Connor V Duffy, Massachusetts Institute of Technology, Bioengineering, Cambridge, MA, United States, cvduffy@mit.edu
Dr. Laurent David, Université Claude Bernard - Lyon 1, Ingénierie des Matériaux Polymères, Lyon, France, laurent.david@univ-lyon1.fr
Dr. Thomas Crouzier, Massachusetts Institute of Technology, Bioengineering, Cambridge, MA, United States, Email1